Stock listing

NASDAQ:ZNTL Zentalis Pharmaceuticals, Inc. Stock

Home listing (NASDAQ) of Zentalis Pharmaceuticals, Inc.

Follow Zentalis Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ZNTL

$2.13 USD -0.11 (-4.9%)

Close on Oct 16, 2026

Zentalis Pharmaceuticals, Inc. logo
Ticker
NASDAQ:ZNTL
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Zentalis Pharmaceuticals, Inc. news

Financings

  • Public offering of common stock

    Aug 18, 2026

    Closed: US$92.6M raised · US$3.5 a share · TD Cowen +4

    Dealers: TD Cowen (co-lead), Guggenheim Securities (co-lead), Oppenheimer & Co. (co-lead), H.C. Wainwright & Co., Rodman & Renshaw LLC

    Use of proceeds: Fund clinical trials, preclinical studies, regulatory filings, manufacturing, companion diagnostic, pre-commercial activities, working capital and general purposes

    Announced Aug 13, 2026 · Update Aug 14, 2026 · Closed Aug 17, 2026 · Closed Aug 18, 2026

Read by 6ix AI from the company's releases

Decks

Zentalis Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
22 in the last 12 months · 110 in all · newest Oct 1, 2026 · oldest 2020
Decks
22 decks · latest August 2026

Where Zentalis Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ZNTL · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ZNTLBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Zentalis Pharmaceuticals, Inc.